Research & Development: Page 100


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Avtar Dhillon - Successful Returns

    Avtar Dhillon – Successful Returns October 2005 PharmaVOICE A scientist’s perseverance and foresight, a doctor’s compassion, and an entrepreneur’s penchant for turning business opportunities into successful ventures are just some of the traits that define the multifaceted career of Avtar D...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    On the Cover The management of customer relationship management Having lagged behind other industries in terms of capitalizing on customer data, the pharmaceutical arena is catcthing up. The industry is beginning to fully commit to learn more about its customers, and is using that information to ...

    By PharmaVoice Team • Jan. 2, 2008
  • Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Letters

    Putting the “Community” in Community Service A call to action Hurricane Katrina damaged or destroyed dozens of research sites along the Gulf Coast and dislocated hundreds of employees and thousands of study participants. Pharmaceutical and biotechnology companies reacted quickly ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Road to Personalized Medicine

    On the Road to Personalized Medicine The use of biomarkers in clinical drug development will usher in the age of personalized medicine, allowing developers to predict a patient’s response to a compound. The result will be not only better treatment for patients, ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    5th Annual PharmaLinx Charity Golf Outing

    5th Annual PharmaLinx Charity Golf Outing Raising More than $20,000 for the Lankenau Institute for Medical Research Hosted by PharmaVoice Magazine and AXIS Healthcare Communications LLC 1. Dr. Vincent Cristofalo from Lankenau Institute (LIMR) and Lisa Banket from PharmaVOICE share a momen...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New healthcare-related products, services, and companies GfK Group Integrates U.S. Healthcare Businesses GfK Group has consolidated its U.S. healthcare activities under GfK U.S. HealthCare Companies. This move follows GfK’s acquisition of NOP World, as well as its full acquisition of G...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    ECG Goes Digital

    ECG Goes Digital By Denise Myshko With regulatory agencies placing a greater emphasis on cardiac safety, pharmaceutical companies are now required to test all drugs for their impact on cardiac repolarization. Electronic data capture and transfer technologies are making this a much more manageable...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    Suite of Technology Solutions Addresses Safety Issues Life-sciences organizations face increasing scrutiny from consumers, healthcare professionals, regulatory agencies, and legislators. As a result, it is critical that they take a proactive approach to the way adverse-event cases are received, p...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Six Sigma: Quality Improvement Programs

    Six Sigma: Quality Improvement Programs Implementing a six sigma quality improvement program is not a magic pill to instantly improve business performance. Instead it is a structured way to improve the product or service delivered to customers while improving business efficiency. The Six Sigma qu...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The CRA: A Key to Site Effectiveness

    The CRA: A Key to Site Effectiveness Clinical Research Associates By Denise Myshko Electronic data capture and other clinical-research technologies are having a far-reaching impact that extends beyond just the quick and efficient gathering of data. Clinical research associates — employed by the s...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's on Your Mind -- Opinions

    Opinions Six Sigma: A Process Strategy The vision for Six Sigma is not just about bottom-line savings. Within the last few years, Six Sigma programs have become geared toward stimulating top-line growth by focusing on critical aspects of company-centric design processes. PharmaVOICE asked: Does y...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents September 2005 On the Cover Pharmaceutical industry image: Regaining the trust Repairing the pharmaceutical industry’s tarnished image is a major undertaking that many believe has barely begun. All sectors of the industry need to unite behind a single message and purpose: to res...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    In June, PharmaVOICE hosted its first Pharmaceutical Marketers KnowledgeShare Forum, a two-day event that brought together top-level executives from throughout the industry to engage in a meaningful dialogue on a number of subjects impacting the marketing sector. On the second day of this event, ...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The PharmaVOICE 100 - Letter from the Editor

    The PharmaVOICE 100 was inspired by the men and women who graciously consent to share their insights on the various trends and challenges facing the life-sciences industry on a monthly basis. We are continually fired up by their knowledge and willingness to raise their voices and bring their uniq...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents The Commanders and Chiefs From the presidents of major pharmaceutical companies to top executives at specialty and biotechnology companies to the leaders of companies that support the industry, these men and women are shaping the life-sciences industry. The Risk Takers The archi...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Commanders and Chiefs

    PharmaVOICE 100 These top-level executives are at the forefront, leading change within the industry and guiding their companies to success. Guided by Values David Mott It has been said that how individuals respond to adversity often defines their character. David Mott, president, CEO, and vice ch...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Risk Takers

    Taking the World by Storm Five years ago, during a cab ride in New York City the idea for the Institute for OneWorld Health, the nation’s only nonprofit pharmaceutical company, was born. The African cabbie’s comment that pharmaceutical companies have all the money ignited the fire. The passenger ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Dorland Launches inRx Medical Education Independent company formed to respond to increasing regulatory standards. In response to growing concerns about regulatory oversight and the need to separate continuing medical-education programs from company-sponsored marketing activities, Dorland has crea...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    PharmaTrax Worldwide Hormonal Contraceptive Market to Increase The world market for hormonal contraceptive products will surpass $6 billion in 2005, according to a new report from Kalorama Information. The report, Markets in Human Reproductive Medicine: Contraception and Infertility Management, c...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Richard Pascoe -- An Officer & A Leader

    An Officer & A Leader July 2005 From the military to the semiconductor industry to the life-sciences industry, Richard Pascoe has drawn on his leadership skills — team building and staff motivation, combined with courage, integrity, and character — to bring out the best in his people for the ...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Teri Cox says the public isn’t aware of the industry’s role in patient advocacy. Dr. Paul Bleicher says it’s important to consider what components of a CRO will be used when determining budgets. Contents Richard Pascoe says leadership is understanding what motivates people. July 2005 On the Cover...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Letters

    Letters Are Drug Safety Concerns Endangering Drug Benefits? The best way to avoid draconian restrictions on consumer and doctor access to the world’s most innovative medicines is to strike an appropriate balance between benefits and risks. — Rob Norton A Congressional overreaction For starters, I...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Communicating cooperatively Letter from the Editor July 2005 In June, an unprecedented number of exhibitors and attendees convened in Washington, D.C., to attend the annual Drug Information Association (DIA) conference. The DIA annual meeting provides a neutral forum for regulators, academics, an...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool July 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Marcus Carr Novo Nordisk Names Chief Medical Officer Marcus Carr, M.D., Ph.D., has joined Novo Nordisk as chief medical officer and executive director for clinical research of the hemostasis gro...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    July 18-19 The 2nd Annual Strategic Medicare Compliance and Administration Summit Ritz Carlton Hotel, Tysons Corner, Va. For more information, contact Jon Stock, The Center for Business Intelligence, at 800-817-8601, e-mail [email protected], or visit cbinet.com. July 18-19 9th International Out...

    By PharmaVoice Team • Jan. 2, 2008